Captrust Financial Advisors Surface Oncology, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$1.42 - $3.15 $71 - $157	-50 Reduced 2.63%	1,850 $3,000
Q1 2022 May 16, 2022	SELL	$2.65 - $5.08 $2,650 - $5,080	-1,000 Reduced 34.48%	1,900 $6,000
Q2 2021 Aug 16, 2021	SELL	$6.45 - $9.09 $12,255 - $17,271	-1,900 Reduced 39.58%	2,900 $22,000
Q1 2021 May 17, 2021	BUY	$7.25 - $13.82 $34,075 - $64,954	4,700 Added 4700.0%	4,800 $37,000
Q4 2020 Feb 16, 2021	BUY	$6.87 - $10.48 $687 - $1,048	100 New	100 $1,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.